Nexien BioPharma
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Nexien BioPharma's balance sheet done over the years? Its assets were worth $4,183 last year, which is less than in the previous period. 8736% of Nexien BioPharma’s total assets is currently financed by debt. Its liabilities reached the amount of $365,432, which means an increase by 24% compared compared to last year.
Debt to Assets
| 2015 | 0 | 48.91K | Infinity% |
|---|---|---|---|
| 2016 | 0 | 69.90K | Infinity% |
| 2017 | 773692 | 210.40K | 27.19% |
| 2018 | 1272321 | 88.78K | 6.98% |
| 2019 | 310670 | 44.75K | 14.4% |
| 2020 | 22786 | 29.15K | 127.93% |
| 2021 | 25541 | 39.31K | 153.93% |
| 2022 | 124518 | 242.12K | 194.45% |
| 2023 | 43127 | 295.13K | 684.34% |
| 2024 | 4183 | 365.43K | 8736.12% |
NXEN Balance Sheet (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 4.18K | 35.14K | 116.89K | 18.04K | 10.78K | 146.35K | 819.73K | 242.77K | 0 | 0 |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 0 | 0 | 0 | 0 | 0 | 0 | 15K | 141.32K | 0 | 0 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | -15B | -141.32K | 0 | 0 |
Other current assets | 0 | 7.98K | 7.62K | 7.5K | 12K | 64.64K | 15B | 0 | 0 | 0 |
Total current assets | 4.18K | 43.12K | 124.51K | 25.54K | 22.78K | 310.67K | 834.73K | 384.10K | 0 | 0 |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 337.91K | 302.91K | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 570.67K | 0 | 0 |
Other non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 99.66K | -484K | 0 | 0 |
Total non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 437.58K | 389.58K | 0 | 0 |
Total assets | 4.18K | 43.12K | 124.51K | 25.54K | 22.78K | 310.67K | 1.27M | 773.69K | 0 | 0 |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | -295.13B | 0 | 0 | -17.11K | 0 | 0 | 0 | 0 | 0 |
Short term debt | 312.25K | 271.49K | 176.72K | 12.94K | 12K | 0 | 0 | 0 | 0 | 0 |
Total current liabilities | 365.43K | 295.13K | 242.12K | 39.31K | 29.15K | 44.75K | 88.78K | 210.40K | 69.90K | 48.91K |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 197.12K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total non-current liabilities | 0 | -5 | 197.12K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total liabilities | 365.43K | 295.13K | 242.12K | 39.31K | 29.15K | 44.75K | 88.78K | 210.40K | 69.90K | 48.91K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |